Cord blood injection could ease lower back pain

NCT ID NCT06415461

Ongoing Symptom relief Sponsor: University of Florida Source: ClinicalTrials.gov ↗

First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This early-stage trial tests a special cord blood product (CFL001) in 9 adults with chronic sacroiliac joint pain. The main goal is to check safety, but researchers will also look for signs of pain relief and improved quality of life. Participants receive a single injection, and the study will track side effects and changes in pain scores over time.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: umbilical cord blood product (CFL001)
What this could lead to: If safe and effective, this could point toward a new way to ease chronic sacroiliac joint pain without surgery.
What could go wrong: This is a very early, tiny Phase 1 trial with only 9 people, focused mainly on safety. It is too small to prove if the treatment works, and results may not apply to everyone.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PAIN, BACK are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Back Pain Pain

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

PAIN, BACK SACROILIAC; BACKACHE

Contacts and locations

Locations

University of Florida Pain Clinic

Gainesville, Florida, 32610, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.